S Mudaliar, P Mohideen, R Deutsch, TP Ciaraldi, D … - Diabetes care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In this single-center, randomized, double-blind, crossover
euglycemic glucose clamp study, 15 healthy male volunteers (aged 27 ± 4 years, BMI 24.2 ±
0.7 kg/m 2 [mean ± SE]) received a primed continuous intravenous infusion of 40 mU/m 2 ... Cited by 13 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org J Westerbacka, R Bergholm, M Tiikkainen, H … - … , and vascular biology, 2004 - Am Heart Assoc Methods and Results— Ten healthy men (age: 33±9 years [mean±SD]; BMI: 23±2 kg/m 2 ) were
studied on two separate occasions in a double-blind, randomized, crossover fashion. In each
study, blood flow responses to intrabrachial artery infusions of ACh and SNP were ... Cited by 12 - Related articles - BL Direct - All 10 versions
[CITATION] Is there a need for better basal insulin
HE Scholtz, SG Pretorius, DH Wessels, C Venter, MA … - Acta Diabetologica, 2003 - Springer Abstract The absolute glucose disposal of insulin glargine (Lantus) was compared to that of regular
human insulin in healthy subjects (n=20) using the euglycaemic clamp tech- nique in a
single-dose, double-blind, randomized, two-way crossover design. Subjects received 30- ... Cited by 5 - Related articles - BL Direct - All 3 versions
[CITATION] The endocrine pancreas and the control of blood glucose
GU Kuerzel, U Shukla, HE Scholtz, SG … - Current Medical …, 2003 - informahealthcare.com Objective: It is important to establish pharmacokinetic or pharmacodynamic differences between
novel insulin analogues and human insulin. This study examined the primary metabolic degradation
products of insulin glargine (LANTUS*) in humans. Design: In this single dose, open-label ... Cited by 17 - Related articles - BL Direct - All 9 versions
[CITATION] … on endogenous glucose output and peripheral activation/deactivation kinetic …
